Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang Shi

Showing results (1241-1250 of 1,367) with videos related to

Pageof 137
Sort By:
The Lancet. Oncology|January 21, 2014
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trialYi-Long Wu, Caicun Zhou, Cheng-Ping Hu, et al.
Journal of Clinical Medicine|October 14, 2022
Meeting the Challenges of Myocarditis: New Opportunities for Prevention, Detection, and Intervention-A Report from the 2021 National Heart, Lung, and Blood Institute WorkshopDaniela Čiháková, Yang Shi, Bishow Adhikari, et al.
Blood Advances|January 3, 2024
Biological signatures of the International Prognostic Index in diffuse large B-cell lymphomaYue Wang, Qing Shi, Zi-Yang Shi, et al.
Journal of the American Chemical Society|June 12, 2020
Potent and Prolonged Innate Immune Activation by Enzyme-Responsive Imidazoquinoline TLR7/8 Agonist Prodrug VesiclesBi Wang, Simon Van Herck, Yong Chen, et al.
Oncology Letters|October 4, 2019
MicroRNA-23a inhibits endometrial cancer cell development by targeting SIX1Hong-Lin Li, Jun-Jie Sun, Hui Ma, et al.
Biomarker Research|March 6, 2023
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumorsDingwei Ye, Jayesh Desai, Jingwen Shi, et al.
Redox Biology|June 11, 2025
ZNFX1 suppresses apoptosis-associated mRNA stability in cardiomyocyte to protect against myocardial infarctionYang Shi, Zeqi Sun, Yongchao Chen, et al.
Advanced Therapeutics|October 8, 2024
Repurposing Tamoxifen for Tumor Microenvironment Priming and Enhanced Tumor-Targeted Drug DeliveryIlaria Biancacci, Daniele De Santis, Elena Rama, et al.
Hepatology (Baltimore, Md.)|June 30, 2021
Involvement of TIGIT in Natural Killer Cell Exhaustion and Immune Escape in Patients and Mouse Model With Liver Echinococcus multilocularis InfectionChuanshan Zhang, Hui Wang, Jing Li, et al.
Leukemia & Lymphoma|July 10, 2023
Acute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1 upregulationJiani Chai, Jui Choudhuri, Qing Wang, et al.
Pageof 137

Showing results (1241-1250 of 1,367) with videos related to

Sort By:
Pageof 137
The Lancet. Oncology|January 21, 2014
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trialYi-Long Wu, Caicun Zhou, Cheng-Ping Hu, et al.
Journal of Clinical Medicine|October 14, 2022
Meeting the Challenges of Myocarditis: New Opportunities for Prevention, Detection, and Intervention-A Report from the 2021 National Heart, Lung, and Blood Institute WorkshopDaniela Čiháková, Yang Shi, Bishow Adhikari, et al.
Blood Advances|January 3, 2024
Biological signatures of the International Prognostic Index in diffuse large B-cell lymphomaYue Wang, Qing Shi, Zi-Yang Shi, et al.
Journal of the American Chemical Society|June 12, 2020
Potent and Prolonged Innate Immune Activation by Enzyme-Responsive Imidazoquinoline TLR7/8 Agonist Prodrug VesiclesBi Wang, Simon Van Herck, Yong Chen, et al.
Oncology Letters|October 4, 2019
MicroRNA-23a inhibits endometrial cancer cell development by targeting SIX1Hong-Lin Li, Jun-Jie Sun, Hui Ma, et al.
Biomarker Research|March 6, 2023
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumorsDingwei Ye, Jayesh Desai, Jingwen Shi, et al.
Redox Biology|June 11, 2025
ZNFX1 suppresses apoptosis-associated mRNA stability in cardiomyocyte to protect against myocardial infarctionYang Shi, Zeqi Sun, Yongchao Chen, et al.
Advanced Therapeutics|October 8, 2024
Repurposing Tamoxifen for Tumor Microenvironment Priming and Enhanced Tumor-Targeted Drug DeliveryIlaria Biancacci, Daniele De Santis, Elena Rama, et al.
Hepatology (Baltimore, Md.)|June 30, 2021
Involvement of TIGIT in Natural Killer Cell Exhaustion and Immune Escape in Patients and Mouse Model With Liver Echinococcus multilocularis InfectionChuanshan Zhang, Hui Wang, Jing Li, et al.
Leukemia & Lymphoma|July 10, 2023
Acute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1 upregulationJiani Chai, Jui Choudhuri, Qing Wang, et al.
Pageof 137